Acarix: Providing Ease and Peace through Innovative Medical Solutions
Innovation in the healthcare niche means innovation in the complete lifecycle of medical devices from conceptualization to the end of l...
State-of-the-Art Cardiology Clinic enhances patient care with CADScor System
Acarix, a leader in acoustic and AI-based cardiac diagnostics, announces today that Abo-Auda Associates Cardiologists in Texoma, Texas ...
Acarix Awarded Business Sweden 2023 Catalyst Program Award
Acarix, a leader in acoustic and AI-based cardiac diagnostics, is pleased to announce they have been awarded the 2023 Catalyst Program ...
Acarix to present Q1 2023 Report
CEO Helen Ljundahl Round and CFO Christian Lindholm present the company’s Q1 2023 report.
Acarix to present at Redeye Medtech Event
Acarix presents at the Redeye Medtech Event
Acarix and the American College of Cardiology collaborate on first edition framework for CADScor System
Acarix, a leader in acoustic and AI-based cardiac diagnostics, announced today, in collaboration with the American College of Cardiolog...
Acarix to present at Redeye Investor Forum
Acarix to Present at the Redeye Investor Forum. A live broadcast where different companies, including Acarix, will show a 12-minute pre...
The exercise period for Acarix warrants of series 2022:U begins today
In December 2022, Acarix AB (publ) (“Acarix” or the “Company”) carried out a rights issue of shares and warrants of series 2022:U (the ...
Acarix to present at the 2023 Aktiespararna Share Day in Stockholm
Acarix will present at the 2023 Aktiespararna Share Day in Stockholm on May 3, 2023Nine CEOs, including Acarix CEO Helen Ljungdahl Roun...
Acarix AB Annual Report 2022
Acarix, a leader in acoustic and AM-based cardiac diagnostics, today announces that the Annual Rport for 2022 is available as a pdf on ...
Notice of Annual General Meeting in Acarix AB
The shareholders of Acarix AB, reg. no. 559009-0667, (the "Company"), are hereby convened to the annual general meeting to be...
Study published in Heart strengthens diagnostic value of Acarix CADScor System
The study confirms that the CADScor System has a very high rule-out accuracy in low-risk patients with chest pains, and potential to re...